Combined Pre- and Post-capillary Pulmonary Hypertension Clinical Trials

Combined Pre- and Post-capillary Pulmonary Hypertension

Explore clinical trials studying Combined Pre- and Post-capillary Pulmonary Hypertension. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Combined Pre- and Post-capillary Pulmonary Hypertension trial results

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

NCT07147114

Conditions: Combined Pre- and Post-capillary Pulmonary Hypertension, CpcPH, Group 2 Pulmonary Hypertension, +2 more
Locations: Pusan National University Hospital Busan, South Korea

Chungbuk National University Hospital Chungju, South Korea

Keimyung University Dongsan Hospital Daegu, South Korea

Chungnam National University Hospital Daejeon, South Korea

View all 15 locations

View Trial Details

Combined Pre- and Post-capillary Pulmonary Hypertension

Combined Pre- and Post-capillary Pulmonary Hypertension trial results

Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Related conditions